[Federal Register Volume 80, Number 244 (Monday, December 21, 2015)]
[Notices]
[Pages 79385-79386]
[FR Doc No: 2015-31935]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-76648; File No. SR-Phlx-2015-49]

Self-Regulatory Organizations; NASDAQ OMX PHLX LLC; Notice of
Designation of a Longer Period for Commission Action on Proceedings To
Determine Whether To Approve or Disapprove a Proposed Rule Change To
Amend and Correct Rule 1080.07

December 15, 2015.
    On June 5, 2015, NASDAQ OMX PHLX LLC (the ``Exchange'' or ``Phlx'')
filed with the Securities and Exchange Commission (``Commission''),
pursuant to section 19(b)(1) of the Securities Exchange Act of 1934
(``Act'') \1\ and Rule 19b-4 thereunder,\2\ a proposed rule change to
amend and correct several provisions in Phlx Rule 1080.07, which
governs the trading of Complex Orders on Phlx XL. The proposed rule
change was published for comment in the Federal Register on June 23,
2015.\3\ On July 30, 2015, the Commission extended the time period for
Commission action to September 21, 2015.\4\ On September 17, 2015, the
Commission instituted proceedings under section 19(b)(2)(B) of the Act
\5\ to determine whether to approve or disapprove the proposed rule
change.\6\ The Phlx filed Amendment Nos. 1 and 2 to the proposal on
November 4, 2015, and December 3, 2015, respectively.\7\ The Commission
received no comments regarding the proposal.\8\
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ See Securities Exchange Act Release No. 75189 (June 17,
2015), 80 FR 35997.
    \4\ See Securities Exchange Act Release No. 75570, 80 FR 46619
(August 5, 2015).
    \5\ 15 U.S.C. 78s(b)(2)(B).
    \6\ See Securities Exchange Act Release No. 75942, 80 FR 57406
(September 23, 2015).
    \7\ When the Phlx filed Amendment Nos. 1 and 2 with the
Commission, it also posted the amendments on the Phlx's Web site and
submitted the amendments as a comment letters to the file, which the
Commission posted on its Web site and placed in the public comment
file for SR-Phlx-2015-49.
    \8\ As noted above, the Phlx submitted Amendment Nos. 1 and 2 to
the comment letter file for SR-Phlx-2015-49.
---------------------------------------------------------------------------

    Section 19(b)(2) of the Act provides that proceedings to determine
whether to disapprove a proposed rule change must be concluded within
180 days of the date of publication of notice of filing of the proposed
rule change.\9\ The time for conclusion of the proceedings may be
extended for up to 60 days if the Commission determines that a longer
period is appropriate and publishes the reasons for such
determination.\10\ The 180th day for this filing is December 20, 2015.
---------------------------------------------------------------------------

    \9\ 15 U.S.C. 78s(b)(2)(B)(i)(II) and (ii)(I).
    \10\ 15 U.S.C. 78s(b)(2)(B)(ii)(II).
---------------------------------------------------------------------------

    The Commission is extending the time period for Commission action
on the proposed rule change. The Commission finds that it is
appropriate to designate a longer period within which to take action on
the proposed rule change so that it has sufficient time to consider the
issues raised by the proposal and to take action on the Exchange's
proposed rule change.
    Accordingly, pursuant to section 19(b)(2)(B)(ii)(II) of the Act
\11\ and for the reasons stated above, the Commission designates
February 18, 2016, as the date by which the Commission should either
approve or disapprove the proposed rule change (File No. SR-Phlx-2015-
49).
---------------------------------------------------------------------------

    \11\ Id.

---------------------------------------------------------------------------

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\12\
---------------------------------------------------------------------------

    \12\ 17 CFR 200.30-3(a)(57).
---------------------------------------------------------------------------

Robert W. Errett,
Deputy Secretary.
[FR Doc. 2015-31935 Filed 12-18-15; 8:45 am]
BILLING CODE 8011-01-P


October 7, 2002 Donald R. Lynam Vice President, Air Conservation Ethyl Corporation 330 South Fourth Street Richmond, VA 23219 4304 Dear Dr. Lynam,

On July 30, 2002, the Ethyl Corporation ( Ethyl) submitted to the Environmental Protection Agency ( EPA) a health study protocol for MMT as required under the Alternative Tier 2 Health Effects Testing Requirements. The protocol submission deals with revised protocols associated with the 90 day primate pharmacokinetic ( PK) health study. These requirements were finalized in the notification received by Ethyl on May 25, 2000. As you know, the notification requires EPA review and approval of these protocols.

The revised protocol had two main changes involving the addition of two animals to the control and low dose exposure groups, and the addition of two animals to serve as replacements, if needed. We believe that both of these changes will strengthen the study design. Also, the Chemical Industry Institute of Toxicology ( CIIT) indicates that, depending on the laboratory used, clinical chemistry and hematology assessments may not be performed under the U. S. EPA's Good Laboratory Practices regulations. In this particular case, we believe this is acceptable as long as the laboratories maintain records clearly indicating how samples were tracked and managed. This letter conveys the Agency's approval of the July 30, 2002, revised protocol.

If you have any questions concerning our review, please contact Joe Sopata of my staff at ( 202) 564 9034.

Sincerely,

/ s/

Suzanne Rudzinski Director Transportation and Regional Programs Division cc: Tim Backstrom, OGC Kevin Fast, Hunton & Williams